amrinone , 100 mg orally every 8 hours , was administered to 13 patients with moderate-to-severe congestive heart failure ( chf ) for 1 month on an outpatient basis to determine the beneficial and undesirable effects of this new cardioactive agent in this clinical setting .
C0002697
amrinone
C0018802
congestive heart failure